全文获取类型
收费全文 | 9504篇 |
免费 | 886篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 351篇 |
妇产科学 | 310篇 |
基础医学 | 1175篇 |
口腔科学 | 283篇 |
临床医学 | 980篇 |
内科学 | 2019篇 |
皮肤病学 | 100篇 |
神经病学 | 577篇 |
特种医学 | 369篇 |
外科学 | 1635篇 |
综合类 | 215篇 |
现状与发展 | 20篇 |
一般理论 | 10篇 |
预防医学 | 469篇 |
眼科学 | 364篇 |
药学 | 490篇 |
中国医学 | 33篇 |
肿瘤学 | 991篇 |
出版年
2024年 | 10篇 |
2023年 | 97篇 |
2022年 | 34篇 |
2021年 | 230篇 |
2020年 | 166篇 |
2019年 | 198篇 |
2018年 | 299篇 |
2017年 | 177篇 |
2016年 | 220篇 |
2015年 | 281篇 |
2014年 | 370篇 |
2013年 | 403篇 |
2012年 | 561篇 |
2011年 | 648篇 |
2010年 | 429篇 |
2009年 | 419篇 |
2008年 | 573篇 |
2007年 | 611篇 |
2006年 | 585篇 |
2005年 | 521篇 |
2004年 | 466篇 |
2003年 | 420篇 |
2002年 | 324篇 |
2001年 | 319篇 |
2000年 | 267篇 |
1999年 | 225篇 |
1998年 | 98篇 |
1997年 | 99篇 |
1996年 | 98篇 |
1995年 | 70篇 |
1994年 | 66篇 |
1993年 | 62篇 |
1992年 | 118篇 |
1991年 | 106篇 |
1990年 | 109篇 |
1989年 | 107篇 |
1988年 | 82篇 |
1987年 | 83篇 |
1986年 | 72篇 |
1985年 | 67篇 |
1984年 | 45篇 |
1983年 | 44篇 |
1982年 | 35篇 |
1981年 | 31篇 |
1980年 | 26篇 |
1979年 | 24篇 |
1978年 | 29篇 |
1977年 | 32篇 |
1976年 | 22篇 |
1975年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
1.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
2.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention 下载免费PDF全文
3.
PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease 下载免费PDF全文
4.
5.
6.
Prevalence of Potentially Inappropriate Prescribing Among Hong Kong Older Adults: A Comparison of the Beers 2003, Beers 2012, and Screening Tool of Older Person's Prescriptions and Screening Tool to Alert doctors to Right Treatment Criteria 下载免费PDF全文
7.
V Aerra M Kuduvalli AN Moloto AK Srinivasan AD Grayson BM Fabri AY Oo 《Journal of cardiothoracic surgery》2006,1(1):6-5
Background
Atrial fibrillation can occur in up to 40% of patients undergoing coronary surgery. 相似文献8.
Paul Wexberg MD BM Richard Pacher MD Suzanne Rdler MD Katharina Kiss MD Gilbert Beran MD Michael Grimm MD Gerald Maurer MD Dietmar Glogar MD FESC 《The Journal of heart and lung transplantation》2002,21(12):583-1263
BACKGROUND: Endothelin, a peptide with strong vasoconstrictive and mitogenic properties, has been found to increase after cardiac transplantation. We therefore assessed the association between its precursor peptide, big endothelin-1, and intimal hyperplasia and coronary flow reserve after heart transplantation. METHODS: Thirty-five patients without hemodynamically significant coronary artery disease after heart transplantation were investigated: Average peak flow velocity in the left anterior descending artery (LAD) was assessed by intracoronary Doppler at baseline as well as after injection of adenosine; coronary flow reserve was calculated as a ratio of both and was corrected for patient age and baseline average peak flow velocity. Lumen, intima + media and total vessel area were measured by intracoronary ultrasound. The plasma concentration of big endothelin-1 in venous blood was determined by radioimmunoassay. RESULTS: Patients with elevated big endothelin-1 levels (>2 fmol/ml) tended to have a decreased corrected coronary flow reserve (2.60 +/- 0.9 vs 3.21 +/- 1.0, p = 0.078). They also had a significantly larger intima + media area (5.82 +/- 2.9 vs 2.37 +/- 2.9 mm(2), p = 0.004) and total vessel area (18.36 +/- 5.8 vs 12.81 +/- 4.8 mm(2), p = 0.012) than those with normal plasma concentrations. CONCLUSIONS: Our study suggests an association between elevated big endothelin-1 plasma levels and the development of intimal hyperplasia and reduction of coronary flow reserve after cardiac transplantation. 相似文献
9.
10.
Rifampin alone or with trimethoprim for contacts of children with Haemophilus influenzae type b infections. 总被引:1,自引:0,他引:1 下载免费PDF全文
T Jadavji R Cheung R M Bannatyne C G Prober 《Canadian Medical Association journal》1986,135(4):328-331
We carried out a nonrandomized, unblinded study to compare the efficacy of rifampin alone with that of rifampin in combination with trimethoprim in the eradication of the Haemophilus influenzae type b (HIB) carrier state among contacts of patients with invasive HIB infection. The study population comprised 17 index patients admitted to hospital with severe HIB infections and 233 contacts, 43 of whom had nasopharyngeal colonization with HIB of the same biotype as that of the index patient. Rifampin in a daily dose of 20 mg/kg (maximum 600 mg) for 4 days eradicated the carrier state in 86% of cases, as did the combination of rifampin at the same dosage and trimethoprim in a daily dose of 5 mg/kg (maximum 160 mg) for 4 days. 相似文献